Saltar al contenido
Merck

Parenteral iron dextran therapy.

DICP : the annals of pharmacotherapy (1990-02-01)
V J Kumpf, E G Holland
RESUMEN

Parenteral iron therapy is indicated in patients with iron-deficiency anemia associated with conditions that interfere with the ingestion or absorption of oral iron. Replacement doses of iron required to replenish iron stores are based on body weight and the observed hemoglobin value. Methods of administering iron dextran are reviewed, including intramuscular and intravenous injections of the undiluted drug, intravenous infusion of a diluted preparation, and as an addition to parenteral nutrition solutions. The overall incidence of adverse reactions associated with the parenteral administration of iron is low, but the potential for an anaphylactic reaction requires that an initial test dose be given followed by careful patient observation.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Iron–Dextran, 95-105 mg/mL (Iron content), solution